 | • レポートコード：B-MOR-08434 • 出版社/出版日：Mordor Intelligence / 2018年5月21日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、疼痛管理の世界市場について調べ、疼痛管理の世界規模、市場動向、市場環境、種類別（神経刺激装置、鎮痛剤注入ポンプ）分析、用途別（神経因性疼痛、がん性疼痛 、顔面痛・片頭痛、筋骨格系疼痛、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・疼痛管理の世界市場インサイト ・疼痛管理の世界市場環境 ・疼痛管理の世界市場動向 ・疼痛管理の世界市場規模 ・疼痛管理の世界市場規模：種類別（神経刺激装置、鎮痛剤注入ポンプ） ・疼痛管理の世界市場規模：用途別（神経因性疼痛、がん性疼痛 、顔面痛・片頭痛、筋骨格系疼痛、その他） ・疼痛管理の世界市場：地域別市場規模・分析 ・疼痛管理の北米市場規模・予測 ・疼痛管理のアメリカ市場規模・予測 ・疼痛管理のヨーロッパ市場規模・予測 ・疼痛管理のアジア市場規模・予測 ・疼痛管理のインド市場規模・予測 ・疼痛管理の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global pain management market is expected to grow at a CAGR of 8.4% over the forecast period, 2018-2023. Pain management is a medical approach that draws on disciplines in science and alternative healing to study the prevention, diagnosis, and treatment of pain.
High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain
The demand for pain management devices will be driven by the rise in acute and chronic pain as a result of chronic health conditions like osteoarthritis, inflammatory diseases, cancer, degenerative diseases, and rheumatoid arthritis, among others. Traditionally, the treatment of pain involves the usage of opoid and non-opoid therapies. Lately, the increasing awareness about the efficacy of devices has led to their adoption for pain management practices. Moreover, extensive R&D activity and clinical validation of the safety and efficacy of these devices are major factors for the acceptance of pain management devices. This, along with other factors, such as growing demand for long-term pain management among the geriatric population, high proven efficacy of pain management devices for the treatment of chronic pain, and development of novel pain management devices, among others, will lead to the growth of the pain management devices market.
Low Awareness about the Availability and Use of Pain Management Devices
Pain management devices are a new addition to the market and are now very widely known or accepted in the healthcare industry. Also, the general population is not aware of the benefits of the usage of these devices. Along with this, there is a huge lack of special endeavors that will help promote these products, such as television commercials, educational handouts, public exhibitions, etc. This will lead to the slowdown of the market in the forecast years. Other factors that can affect the growth of this market negatively include shortage of pain specialists, low number of pain clinics in several countries, and high procedural and purchase cost of pain management devices.
North America to Maintain Lead in the Market
North America and Europe respectively currently hold the largest market share for pain management devices. Asia-Pacific will show the fastest growth over the forecast period. The main factors affecting the growth of the market include a large population base and quickly developing healthcare infrastructure.
Key Developments in the Market:
• April 2018 – NeuroMetrix announced results from a clinical study of its Quell wearable device, touting its ability to treat chronic pain. Results from the trial were published in the Journal of Pain Research, the Waltham, Mass.-based company said.
Major Players: BECTON, DICKINSON AND COMPANY, BOSTON SCIENTIFIC CORPORATION, BRAUN MELSUNGEN AG, HALYARD HEALTH, INC., HOSPIRA, INC. (A SUBSIDIARY OF PFIZER INC.), MEDTRONIC PLC , NEUROTECH NA, INC. (A SUBSIDIARY OF THERAGEN LLC), NEVRO CORP., SMITHS MEDICAL, AND ST. JUDE MEDICAL, INC., amongst others.
Reasons to Purchase the Report
• Current and future pain management devices market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Growing Demand for Long-term Pain Management Among the Geriatric Population
6.1.2 High Proven Efficacy of Pain Management Devices for the Treatment of Chronic Pain
6.1.3 Rise in Acute and Chronic Pain as a Result af Chronic Health Conditions
6.1.4 Development of Novel Pain Management Devices
6.2 Market Restraints
6.2.1 Low Awareness about the Availability and Use of Pain Management Devices
6.2.2 Shortage of Pain Specialists and Low Number of Pain Clinics in Several Countries
6.2.3 High Procedural and Purchase Cost of Pain Management Devices
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type
7.1.1 Neurostimulation Devices
7.1.1.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
7.1.1.2 Spinal Cord Stimulation (SCS) Devices
7.1.2 Analgesic Infusion Pumps
7.1.2.1 Intrathecal Infusion Pumps
7.1.2.2 External Infusion Pumps
7.2 By Application
7.2.1 Neuropathic Pain
7.2.2 Cancer Pain
7.2.3 Facial Pain & Migraine
7.2.4 Musculoskeletal Pain
7.2.5 Others
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 India
7.3.3.2 Australia & New Zealand
7.3.3.3 South Korea
7.3.3.4 Others
7.3.4 Rest of the World
7.3.4.1 Saudi Arabia
7.3.4.2 Brazil
7.3.4.3 Others
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Becton, Dickinson and Company
9.2 Boston Scientific Corporation
9.3 Braun Melsungen AG
9.4 Halyard Health, Inc.
9.5 Hospira, Inc. (A Subsidiary of Pfizer Inc.)
9.6 Medtronic PLC
9.7 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
9.8 Nevro Corp.
9.9 Smiths Medical
9.10 ST. Jude Medical, Inc.
*List Not Exhaustive
10. Future of the Market